British Pharmacopoeia (BP) 2025

Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph.Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

BP 2025 Hard Copy (printed), BP Online and Download

Available 1 August 2024 | Effective 1 January 2025 | Superseding the BP 2024

• A Six-Volume printed edition, Including the BP Veterinary 2025
• A single-user online license expiring on the 31 March 2026
• A single-user download for offline use

What’s new in BP 2025

The BP 2025 supersedes the BP 2024 and becomes legally effective on the 1 January 2025. This edition incorporates new monographs from both the BP and Ph.Eur. along with a significant number of revised monographs.

• 14 new BP monographs 32 new Ph. Eur. monographs. Including two new monographs for Paracetamol Infusion and Paracetamol Oral Solution and a new monograph for Solifenacin Oral Suspension which is accompanied by additional information on the website. This information provides a case study demonstrating how users can scale monograph methods to reduce run times and solvent usage.
• 105 amended BP monographs.
• All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 to 11.5.
• Ph. Eur. supplements 11.6 to 11.8 included as in-year online and download product updates.
• Updated references to new BPCRS included in the BP 2025 to ensure that you remain compliant.